Novel investigational approaches for inhibiting angiogenesis in recurrent glioblastoma Journal Article

  

Authors:	Bambury, R. M.; Morris, P. G.
Article Title:	Novel investigational approaches for inhibiting angiogenesis in recurrent glioblastoma
Keywords:	platelet derived growth factor; vasculotropin; cancer survival; review; cancer recurrence; sorafenib; bevacizumab; raf protein; sunitinib; drug efficacy; drug potentiation; nonhuman; drug targeting; cancer adjuvant therapy; cancer radiotherapy; temozolomide; cytoreductive surgery; stem cell factor receptor; vasculotropin receptor; progression free survival; antineoplastic activity; platelet derived growth factor receptor; irinotecan; glioblastoma; antiangiogenic therapy; nitrosourea; methylated dna protein cysteine methyltransferase; antiangiogenic activity; b raf kinase; dna topoisomerase; phase 2 clinical trial (topic); cd135 antigen; phase 1 clinical trial (topic); human; priority journal
Journal Title:	Anti-Cancer Drugs
Volume:	25
Issue:	6
ISSN:	0959-4973
Publisher:	Lippincott Williams & Wilkins
Date Published:	2014-07-01
Start Page:	611
End Page:	613
Language:	English
DOI:	10.1097/cad.0000000000000104
PROVIDER:	scopus
PUBMED:	24858445
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84901486088&partnerID=40&md5=83c5d8fec6b25cb5b45fcb640da91054
Notes:	Anti-Cancer Drugs -- Export Date: 8 July 2014 -- CODEN: ANTDE -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/53865